(Reuters) - A serious warning on Pfizer Inc's drug that helps quit smoking should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data.

FDA panel recommends dropping serious warning on Pfizer's Chantix
Read More
Bagikan Berita Ini
0 Response to "FDA panel recommends dropping serious warning on Pfizer's Chantix"
Posting Komentar